CL2022000454A1 - Polipéptidos de unión y métodos para fabricarlos (divisional de la solicitud no.201901757) - Google Patents

Polipéptidos de unión y métodos para fabricarlos (divisional de la solicitud no.201901757)

Info

Publication number
CL2022000454A1
CL2022000454A1 CL2022000454A CL2022000454A CL2022000454A1 CL 2022000454 A1 CL2022000454 A1 CL 2022000454A1 CL 2022000454 A CL2022000454 A CL 2022000454A CL 2022000454 A CL2022000454 A CL 2022000454A CL 2022000454 A1 CL2022000454 A1 CL 2022000454A1
Authority
CL
Chile
Prior art keywords
making
methods
binding polypeptides
application divisional
polypeptides
Prior art date
Application number
CL2022000454A
Other languages
English (en)
Inventor
Zachary Shriver
Gregory Babcock
Luke Robinson
Original Assignee
Visterra Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Visterra Inc filed Critical Visterra Inc
Publication of CL2022000454A1 publication Critical patent/CL2022000454A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Se describen los polipéptidos, tal como moléculas de anticuerpo y moléculas de TCR, y métodos para fabricar las mismas. Los polipéptidos pueden usarse para tratar, prevenir, y/o diagnosticar trastornos.
CL2022000454A 2016-12-23 2022-02-24 Polipéptidos de unión y métodos para fabricarlos (divisional de la solicitud no.201901757) CL2022000454A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662438712P 2016-12-23 2016-12-23

Publications (1)

Publication Number Publication Date
CL2022000454A1 true CL2022000454A1 (es) 2023-03-24

Family

ID=61054491

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2019001757A CL2019001757A1 (es) 2016-12-23 2019-06-21 Polipéptidos de unión y métodos para fabricarlos.
CL2022000454A CL2022000454A1 (es) 2016-12-23 2022-02-24 Polipéptidos de unión y métodos para fabricarlos (divisional de la solicitud no.201901757)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2019001757A CL2019001757A1 (es) 2016-12-23 2019-06-21 Polipéptidos de unión y métodos para fabricarlos.

Country Status (15)

Country Link
US (2) US11820979B2 (es)
EP (1) EP3559028A1 (es)
JP (2) JP7360324B2 (es)
KR (1) KR20190111036A (es)
CN (1) CN110366557B (es)
AU (1) AU2017382367A1 (es)
BR (1) BR112019013096A2 (es)
CA (1) CA3045696A1 (es)
CL (2) CL2019001757A1 (es)
CO (1) CO2019006663A2 (es)
IL (1) IL267565A (es)
MX (1) MX2019007356A (es)
MY (1) MY201744A (es)
RU (1) RU2019123063A (es)
WO (1) WO2018119402A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019204226A1 (en) * 2018-04-16 2019-10-24 University Of Massachusetts Compositions and methods for improved gene editing
CN109161572B (zh) * 2018-07-05 2021-11-12 中国海洋大学 单链环状核酸及其制备方法和应用

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
DE3883899T3 (de) 1987-03-18 1999-04-22 Sb2, Inc., Danville, Calif. Geänderte antikörper.
EP0768377A1 (en) 1988-09-02 1997-04-16 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8905669D0 (en) 1989-03-13 1989-04-26 Celltech Ltd Modified antibodies
WO1991000906A1 (en) 1989-07-12 1991-01-24 Genetics Institute, Inc. Chimeric and transgenic animals capable of producing human antibodies
EP0463151B1 (en) 1990-01-12 1996-06-12 Cell Genesys, Inc. Generation of xenogeneic antibodies
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
AU665190B2 (en) 1990-07-10 1995-12-21 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DE69127627T2 (de) 1990-08-29 1998-02-19 Genpharm Int Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper
EP0546091B1 (en) 1990-08-29 2007-01-24 Pharming Intellectual Property BV Homologous recombination in mammalian cells
ES2113940T3 (es) 1990-12-03 1998-05-16 Genentech Inc Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
AU1545692A (en) 1991-03-01 1992-10-06 Protein Engineering Corporation Process for the development of binding mini-proteins
CA2108147C (en) 1991-04-10 2009-01-06 Angray Kang Heterodimeric receptor libraries using phagemids
EP0519596B1 (en) 1991-05-17 2005-02-23 Merck & Co. Inc. A method for reducing the immunogenicity of antibody variable domains
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
ATE427968T1 (de) 1992-08-21 2009-04-15 Univ Bruxelles Immunoglobuline ohne leichtkette
US5851804A (en) 1996-05-06 1998-12-22 Apollon, Inc. Chimeric kanamycin resistance gene
JP2000512852A (ja) 1996-06-17 2000-10-03 バイオダイナミックス アソシエイツ 多成分核酸構築物を調製するための方法及びキット
US20020086330A1 (en) * 2000-01-31 2002-07-04 Rosen Craig A. Nucleic acids, proteins, and antibodies
EP1259601A2 (en) 2000-02-22 2002-11-27 Ahuva Nissim Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
US20060199191A1 (en) 2004-12-13 2006-09-07 Demian Obregon Methods and compositions for the synthesis of RNA and DNA
CN101370832B (zh) * 2005-12-02 2014-07-02 健泰科生物技术公司 结合多肽及其用途
DK2121920T3 (da) 2007-03-01 2011-11-21 Symphogen As Fremgangsmåde til kloning af sammenhørende antistoffer
WO2008104183A2 (en) * 2007-03-01 2008-09-04 Symphogen A/S Recombinant anti-epidermal growth factor receptor antibody compositions
EP3753947A1 (en) 2007-09-14 2020-12-23 Adimab, LLC Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
JP5425180B2 (ja) 2008-03-27 2014-02-26 ザイモジェネティクス， インコーポレイテッド ＰＤＧＦＲβおよびＶＥＧＦ−Ａを阻害するための組成物および方法
WO2010005593A1 (en) * 2008-07-11 2010-01-14 President And Fellows Of Harvard College Systems and methods of droplet-based selection
KR20110058861A (ko) 2008-08-29 2011-06-01 심포젠 에이/에스 조류 유래 항체의 클로닝 방법
EP2449103B1 (en) 2009-06-29 2016-08-03 California Institute of Technology Isolation of unknown rearranged t-cell receptors from single cells
IT1395574B1 (it) 2009-09-14 2012-10-16 Guala Dispensing Spa Dispositivo di erogazione
AU2010328226A1 (en) * 2009-12-07 2012-06-28 Prognosys Biosciences, Inc. Peptide display arrays
EP2572203B1 (en) 2010-05-17 2017-10-25 The Board of Regents of The University of Texas System Determination of antigen-specific antibody sequences in blood circulation
US9146241B2 (en) 2011-11-23 2015-09-29 Board Of Regents, The University Of Texas System Proteomic identification of antibodies
CN103261222B (zh) * 2010-09-10 2017-07-28 医疗免疫有限公司 抗体衍生物
EP2652155B1 (en) 2010-12-16 2016-11-16 Gigagen, Inc. Methods for massively parallel analysis of nucleic acids in single cells
CA2833917C (en) 2011-04-28 2020-04-28 The Board Of Trustees Of The Leland Stanford Junior University Identification of polynucleotides associated with a sample.
US20140243234A1 (en) 2011-08-03 2014-08-28 Texas Biomedical Research Institute Nucleic acid compositions, methods and kits for rapid pairing of affinity agents
EP2794652B1 (en) 2011-12-21 2017-11-15 F. Hoffmann-La Roche AG Rapid method for cloning and expression of cognate antibody variable region gene segments
WO2013116698A2 (en) 2012-02-02 2013-08-08 Invenra, Inc. High throughput screen for biologically active polypeptides
EP2626433B1 (en) * 2012-02-09 2017-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for linking nucleic acids in a microsome from endoplasmatic reticuli
US9708654B2 (en) * 2012-06-15 2017-07-18 Board Of Regents, The University Of Texas System High throughput sequencing of multiple transcripts
CA2876209A1 (en) 2012-06-15 2013-12-19 Adaptive Biotechnologies Corporation Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set
WO2014043813A1 (en) 2012-09-19 2014-03-27 British Columbia Cancer Agency Branch Immune repertoire profiling
SG10201707394PA (en) 2013-03-15 2017-10-30 Adaptive Biotechnologies Corp Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set
US10119134B2 (en) 2013-03-15 2018-11-06 Abvitro Llc Single cell bar-coding for antibody discovery
RU2578009C2 (ru) 2013-05-08 2016-03-20 Закрытое акционерное общество "ЕВРОГЕН" Способ идентификации нативных пар фрагментов днк или рнк, присутствующих в одних и тех же живых клетках
WO2015034928A1 (en) * 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
GB201402591D0 (en) 2014-02-14 2014-04-02 Memo Therapeutics Ag Method for recovering two or more genes, or gene products, encoding an immunoreceptor
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
GB201407852D0 (en) 2014-05-02 2014-06-18 Iontas Ltd Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules
US10202640B2 (en) 2014-05-07 2019-02-12 The Board Of Trustees Of The Leland Stanford Junior University Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing
CA2947320C (en) 2014-05-22 2023-03-14 The University Of British Columbia Methods for determining lymphocyte receptor chain pairs
SG11201702060VA (en) 2014-09-15 2017-04-27 Abvitro Inc High-throughput nucleotide library sequencing
ES2784343T3 (es) 2014-10-29 2020-09-24 Adaptive Biotechnologies Corp Detección simultánea altamente multiplexada de ácidos nucleicos que codifican heterodímeros de receptores inmunes adaptativos emparejados de muchas muestras
US10513733B2 (en) 2015-03-23 2019-12-24 Board Of Regents, The University Of Texas System High throughout sequencing of paired VH and VL transcripts from B cells secreting antigen-specific antibodies
AU2016253964B2 (en) 2015-04-27 2022-07-07 Abvitro Llc Methods of sequencing, determining, pairing, and validating therapeutic agents and disease specific antigens
US9422547B1 (en) 2015-06-09 2016-08-23 Gigagen, Inc. Recombinant fusion proteins and libraries from immune cell repertoires

Also Published As

Publication number Publication date
MY201744A (en) 2024-03-15
JP2023169422A (ja) 2023-11-29
WO2018119402A1 (en) 2018-06-28
JP7360324B2 (ja) 2023-10-12
MX2019007356A (es) 2019-09-05
CL2019001757A1 (es) 2019-11-29
RU2019123063A3 (es) 2021-11-29
EP3559028A1 (en) 2019-10-30
US20180201926A1 (en) 2018-07-19
CN110366557B (zh) 2024-04-09
AU2017382367A1 (en) 2019-06-13
US11820979B2 (en) 2023-11-21
JP2020511117A (ja) 2020-04-16
CN110366557A (zh) 2019-10-22
CA3045696A1 (en) 2018-06-28
CO2019006663A2 (es) 2019-06-28
IL267565A (en) 2019-08-29
US20240141334A1 (en) 2024-05-02
BR112019013096A2 (pt) 2019-12-17
KR20190111036A (ko) 2019-10-01
RU2019123063A (ru) 2021-01-26

Similar Documents

Publication Publication Date Title
CL2022000036A1 (es) Polipéptidos modificados y usos de los mismos (divisional de solicitud no. 201900261)
CL2020003409A1 (es) Moléculas de unión específicas para cd73 y métodos de fabricación de las mismas (divisional de la solicitud no. 201701154)
CL2018002694A1 (es) Moleculas de anticuerpos que se unen a lag-3 y usos de las mismas (divisional solicitud 201602112)
CO2020006900A2 (es) Medios y método para preparar vectores virales y usos de los mismos
CL2018003142A1 (es) Moduladores de la vía de estrés integrada
BR112019012354A2 (pt) anticorpos apenas de cadeia pesada anti-bcma
UY37230A (es) Moduladores de la vía de estrés integrada
EA201890725A1 (ru) Агонисты фарнезоидного х-рецептора и их применение
CR20180013A (es) Anticuerpos anti-tau y métodos de uso.
CL2017002237A1 (es) Proteína de unión de il-18 (il-18bp) y anticuerpos en enfermedades inflamatorias.
BR112018010673A2 (pt) moléculas de anticorpo para april e seus usos
CR20180605A (es) Anticuerpos anti-cd40 y sus usos
CL2019002605A1 (es) Formulaciones que contienen proteínas de unión pd-1 y métodos de fabricación de las mismas.
EA201692529A1 (ru) Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов
CL2022000454A1 (es) Polipéptidos de unión y métodos para fabricarlos (divisional de la solicitud no.201901757)
BR112019006865A2 (pt) caspases induzíveis e métodos para uso
MY196448A (en) Anti-Htra1 Antibodies and Methods of use Thereof
EA201890572A1 (ru) Биофармацевтические композиции
EA201990400A1 (ru) Соединения и композиции и их применение
PH12020550964A1 (en) Heavy chain antibodies binding to cd22
BR112018009745A8 (pt) compostos heterocíclicos para o tratamento de doença
EA202191471A1 (ru) Противовоспалительные полипептиды
TW201713686A (en) Methods for preparing modified von Willebrand factor
EA201790920A1 (ru) Титрованные экстракты cynara scolymus и их применения
AR100041A1 (es) Moléculas de anticuerpo que se unen a lag-3 y usos de las mismas